BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Farrokhyar F, Marshall JK, Easterbrook B, Irvine EJ. Functional gastrointestinal disorders and mood disorders in patients with inactive inflammatory bowel disease: prevalence and impact on health. Inflamm Bowel Dis. 2006;12:38-46. [PMID: 16374257 DOI: 10.1097/01.mib.0000195391.49762.89] [Cited by in Crossref: 198] [Cited by in F6Publishing: 69] [Article Influence: 13.2] [Reference Citation Analysis]
Number Citing Articles
1 Głąbska D, Guzek D, Gałązka K, Lech G. Therapeutic Potential of Proanthocyanidins in Ulcerative Colitis in Remission. J Clin Med 2020;9:E771. [PMID: 32178368 DOI: 10.3390/jcm9030771] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Srinath AI, Goyal A, Zimmerman LA, Newara MC, Kirshner MA, McCarthy FN, Keljo D, Binion D, Bousvaros A, DeMaso DR. Predictors of abdominal pain in depressed pediatric inflammatory bowel disease patients. Inflamm Bowel Dis. 2014;20:1329-1340. [PMID: 24983975 DOI: 10.1097/mib.0000000000000104] [Cited by in Crossref: 20] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
3 Bassotti G, Antonelli E, Villanacci V, Salemme M, Coppola M, Annese V. Gastrointestinal motility disorders in inflammatory bowel diseases. World J Gastroenterol. 2014;20:37-44. [PMID: 24415856 DOI: 10.3748/wjg.v20.i1.37] [Cited by in CrossRef: 45] [Cited by in F6Publishing: 37] [Article Influence: 6.4] [Reference Citation Analysis]
4 Kim ES, Kim KO, Jang BI, Kim EY, Lee YJ, Lee HS, Jeon SW, Kim HJ, Kim SK; Crohn’s and Colitis Association in Daegu-Gyeongbuk (CCAiD). Comparison of 4-L Polyethylene Glycol and 2-L Polyethylene Glycol Plus Ascorbic Acid in Patients with Inactive Ulcerative Colitis. Dig Dis Sci 2017;62:2489-97. [PMID: 28639128 DOI: 10.1007/s10620-017-4634-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
5 Refaie E, García Mateo S, Martínez Domínguez SJ, Gargallo-Puyuelo CJ, Lario Quilez L, Carrera-Lasfuentes P, Arroyo Villarino MT, Gomollón García F. Impact of the lockdown period due to the COVID-19 pandemic in patients with inflammatory bowel disease. Gastroenterol Hepatol 2021:S0210-5705(21)00154-0. [PMID: 34023473 DOI: 10.1016/j.gastrohep.2021.03.012] [Reference Citation Analysis]
6 Mawe GM. Colitis-induced neuroplasticity disrupts motility in the inflamed and post-inflamed colon. J Clin Invest. 2015;125:949-955. [PMID: 25729851 DOI: 10.1172/jci76306] [Cited by in Crossref: 54] [Cited by in F6Publishing: 35] [Article Influence: 9.0] [Reference Citation Analysis]
7 Coates MD, Seth N, Clarke K, Abdul-Baki H, Mahoney N, Walter V, Regueiro MD, Ramos-Rivers C, Koutroubakis IE, Bielefeldt K, Binion DG. Opioid Analgesics Do Not Improve Abdominal Pain or Quality of Life in Crohn's Disease. Dig Dis Sci 2020;65:2379-87. [PMID: 31758431 DOI: 10.1007/s10620-019-05968-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
8 Román AL, Muñoz F. Comorbidity in inflammatory bowel disease. World J Gastroenterol 2011;17:2723-33. [PMID: 21734780 DOI: 10.3748/wjg.v17.i22.2723] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 41] [Article Influence: 5.0] [Reference Citation Analysis]
9 Lucarini E, Coppi E, Micheli L, Parisio C, Vona A, Cherchi F, Pugliese AM, Pedata F, Failli P, Palomino S, Wahl J, Largent-Milnes TM, Vanderah TW, Tosh DK, Jacobson KA, Salvemini D, Ghelardini C, Di Cesare Mannelli L. Acute visceral pain relief mediated by A3AR agonists in rats: involvement of N-type voltage-gated calcium channels. Pain 2020;161:2179-90. [PMID: 32379223 DOI: 10.1097/j.pain.0000000000001905] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
10 Weber AT, Shah ND, Sauk J, Limketkai BN. Popular Diet Trends for Inflammatory Bowel Diseases: Claims and Evidence. Curr Treat Options Gastroenterol 2019;17:564-76. [PMID: 31705371 DOI: 10.1007/s11938-019-00248-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
11 Balmus IM, Ciobica A, Cojocariu R, Luca AC, Gorgan L. Irritable Bowel Syndrome and Neurological Deficiencies: Is There A Relationship? The Possible Relevance of the Oxidative Stress Status. Medicina (Kaunas) 2020;56:E175. [PMID: 32295083 DOI: 10.3390/medicina56040175] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
12 Barbara G, Cremon C, Carini G, Bellacosa L, Zecchi L, De Giorgio R, Corinaldesi R, Stanghellini V. The immune system in irritable bowel syndrome. J Neurogastroenterol Motil. 2011;17:349-359. [PMID: 22148103 DOI: 10.5056/jnm.2011.17.4.349] [Cited by in Crossref: 119] [Cited by in F6Publishing: 104] [Article Influence: 11.9] [Reference Citation Analysis]
13 Srinath AI, Walter C, Newara MC, Szigethy EM. Pain management in patients with inflammatory bowel disease: insights for the clinician. Therap Adv Gastroenterol 2012;5:339-57. [PMID: 22973418 DOI: 10.1177/1756283X12446158] [Cited by in Crossref: 62] [Cited by in F6Publishing: 30] [Article Influence: 6.9] [Reference Citation Analysis]
14 Khera AJ, Chase JW, Salzberg M, Thompson AJV, Woods RJ, Wilson-O'Brien A, Kamm MA. Determinants of long-term function and general well-being in patients with an ileoanal pouch. JGH Open 2021;5:91-8. [PMID: 33490618 DOI: 10.1002/jgh3.12452] [Reference Citation Analysis]
15 Hyphantis TN, Tomenson B, Bai M, Tsianos E, Mavreas V, Creed F. Psychological distress, somatization, and defense mechanisms associated with quality of life in inflammatory bowel disease patients. Dig Dis Sci 2010;55:724-32. [PMID: 19255844 DOI: 10.1007/s10620-009-0762-z] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
16 Srinath AI, Goyal A, Zimmerman LA, Newara MC, Kirshner MA, McCarthy FN, Keljo D, Binion D, Bousvaros A, DeMaso DR. Predictors of abdominal pain in depressed pediatric inflammatory bowel disease patients. Inflamm Bowel Dis. 2014;20:1329-1340. [PMID: 24983975 DOI: 10.1097/mib. 0000000000000104] [Reference Citation Analysis]
17 Bielefeldt K, Davis B, Binion DG. Pain and inflammatory bowel disease. Inflamm Bowel Dis. 2009;15:778-788. [PMID: 19130619 DOI: 10.1002/ibd.20848] [Cited by in Crossref: 145] [Cited by in F6Publishing: 128] [Article Influence: 12.1] [Reference Citation Analysis]
18 Mikocka-Walus AA. Treatment of psychological co-morbidities in common gastrointestinal and hepatologic disorders. World J Gastrointest Pharmacol Ther 2010;1:64-71. [PMID: 21577298 DOI: 10.4292/wjgpt.v1.i2.64] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
19 Ohman L, Simrén M. Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions. Nat Rev Gastroenterol Hepatol. 2010;7:163-173. [PMID: 20101257 DOI: 10.1038/nrgastro.2010.4] [Cited by in Crossref: 362] [Cited by in F6Publishing: 321] [Article Influence: 32.9] [Reference Citation Analysis]
20 Sinagra E, Utzeri E, Morreale GC, Fabbri C, Pace F, Anderloni A. Microbiota-gut-brain axis and its affect inflammatory bowel disease: Pathophysiological concepts and insights for clinicians. World J Clin Cases 2020;8:1013-25. [PMID: 32258072 DOI: 10.12998/wjcc.v8.i6.1013] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
21 Meng J, Agrawal A, Whorwell PJ. Refractory inflammatory bowel disease-could it be an irritable bowel? Nat Rev Gastroenterol Hepatol. 2013;10:58-61. [PMID: 22965430 DOI: 10.1038/nrgastro.2012.173] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
22 Li Q, Guo CH, Chowdhury MA, Dai TL, Han W. TRPA1 in the spinal dorsal horn is involved in post-inflammatory visceral hypersensitivity: in vivo study using TNBS-treated rat model. J Pain Res 2016;9:1153-60. [PMID: 27980434 DOI: 10.2147/JPR.S118581] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
23 De Schepper HU, De Man JG, Van Nassauw L, Timmermans JP, Herman AG, Pelckmans PA, De Winter BY. Acute distal colitis impairs gastric emptying in rats via an extrinsic neuronal reflex pathway involving the pelvic nerve. Gut. 2007;56:195-202. [PMID: 16973715 DOI: 10.1136/gut.2006.104745] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 1.7] [Reference Citation Analysis]
24 Ozer M, Bengi G, Colak R, Cengiz O, Akpinar H. Prevalence of irritable bowel syndrome-like symptoms using Rome IV criteria in patients with inactive inflammatory bowel disease and relation with quality of life. Medicine (Baltimore) 2020;99:e20067. [PMID: 32384473 DOI: 10.1097/MD.0000000000020067] [Cited by in Crossref: 5] [Article Influence: 5.0] [Reference Citation Analysis]
25 Wehkamp J, Götz M, Herrlinger K, Steurer W, Stange EF. Inflammatory Bowel Disease. Dtsch Arztebl Int 2016;113:72-82. [PMID: 26900160 DOI: 10.3238/arztebl.2016.0072] [Cited by in Crossref: 20] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
26 Day AS, Wood JA, Halmos EP, Bryant RV. Practical Guidance for Dietary Management of Patients With Inflammatory Bowel Disease During the SARS-CoV2 Pandemic. J Acad Nutr Diet 2021;121:201-9. [PMID: 32855101 DOI: 10.1016/j.jand.2020.07.019] [Reference Citation Analysis]
27 Gracie DJ, Ford AC. IBS-like symptoms in patients with ulcerative colitis. Clin Exp Gastroenterol. 2015;8:101-109. [PMID: 25733921 DOI: 10.2147/ceg.s58153] [Cited by in Crossref: 22] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
28 Nóbrega AC, Ferreira BR, Oliveira GJ, Sales KM, Santos AA, Nobre E Souza MÂ, Braga LL, Troncon LE, Souza MH. Dyspeptic symptoms and delayed gastric emptying of solids in patients with inactive Crohn's disease. BMC Gastroenterol 2012;12:175. [PMID: 23216812 DOI: 10.1186/1471-230X-12-175] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 1.9] [Reference Citation Analysis]
29 Choi K, Chen J, Mitra S, Sarna SK. Impaired integrity of DNA after recovery from inflammation causes persistent dysfunction of colonic smooth muscle. Gastroenterology. 2011;141:1293-1301, 1301.e1-3. [PMID: 21745450 DOI: 10.1053/j.gastro.2011.06.074] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
30 Parisio C, Lucarini E, Micheli L, Toti A, Di Cesare Mannelli L, Antonini G, Panizzi E, Maidecchi A, Giovagnoni E, Lucci J, Ghelardini C. Researching New Therapeutic Approaches for Abdominal Visceral Pain Treatment: Preclinical Effects of an Assembled System of Molecules of Vegetal Origin. Nutrients 2019;12:E22. [PMID: 31861862 DOI: 10.3390/nu12010022] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
31 Odes S, Friger M, Sergienko R, Schwartz D, Sarid O, Slonim-Nevo V, Singer T, Chernin E, Vardi H, Greenberg D, Israel Ibd Research Nucleus. Simple pain measures reveal psycho-social pathology in patients with Crohn's disease. World J Gastroenterol 2017;23:1076-89. [PMID: 28246482 DOI: 10.3748/wjg.v23.i6.1076] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
32 Gollifer RM, Menys A, Makanyanga J, Puylaert CA, Vos FM, Stoker J, Atkinson D, Taylor SA. Relationship between MRI quantified small bowel motility and abdominal symptoms in Crohn's disease patients-a validation study. Br J Radiol 2018;91:20170914. [PMID: 29888980 DOI: 10.1259/bjr.20170914] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
33 Perera LP, Radigan M, Guilday C, Banerjee I, Eastwood D, Babygirija R, Massey BT. Presence of Irritable Bowel Syndrome Symptoms in Quiescent Inflammatory Bowel Disease Is Associated with High Rate of Anxiety and Depression. Dig Dis Sci. 2019;64:1923-1928. [PMID: 30725303 DOI: 10.1007/s10620-019-05488-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 9.0] [Reference Citation Analysis]
34 Morton H, Pedley KC, Stewart RJC, Coad J. Inflammatory Bowel Disease: Are Symptoms and Diet Linked? Nutrients 2020;12:E2975. [PMID: 33003341 DOI: 10.3390/nu12102975] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
35 Chen Y, Cheng J, Zhang Y, Chen JDZ, Seralu FM. Electroacupuncture at ST36 Relieves Visceral Hypersensitivity via the NGF/TrkA/TRPV1 Peripheral Afferent Pathway in a Rodent Model of Post-Inflammation Rectal Hypersensitivity. J Inflamm Res 2021;14:325-39. [PMID: 33584100 DOI: 10.2147/JIR.S285146] [Reference Citation Analysis]
36 De Schepper HU, De Winter BY, Van Nassauw L, Timmermans JP, Herman AG, Pelckmans PA, De Man JG. TRPV1 receptors on unmyelinated C-fibres mediate colitis-induced sensitization of pelvic afferent nerve fibres in rats. J Physiol. 2008;586:5247-5258. [PMID: 18755744 DOI: 10.1113/jphysiol.2008.159731] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 3.6] [Reference Citation Analysis]
37 Halmos EP, Gibson PR. Dietary management of IBD--insights and advice. Nat Rev Gastroenterol Hepatol. 2015;12:133-146. [PMID: 25645969 DOI: 10.1038/nrgastro.2015.11] [Cited by in Crossref: 47] [Cited by in F6Publishing: 36] [Article Influence: 7.8] [Reference Citation Analysis]
38 Pedersen N, Ankersen DV, Felding M, Wachmann H, Végh Z, Molzen L, Burisch J, Andersen JR, Munkholm P. Low-FODMAP diet reduces irritable bowel symptoms in patients with inflammatory bowel disease. World J Gastroenterol 2017;23:3356-66. [PMID: 28566897 DOI: 10.3748/wjg.v23.i18.3356] [Cited by in CrossRef: 72] [Cited by in F6Publishing: 57] [Article Influence: 24.0] [Reference Citation Analysis]
39 Teruel C, Garrido E, Mesonero F. Diagnosis and management of functional symptoms in inflammatory bowel disease in remission. World J Gastrointest Pharmacol Ther. 2016;7:78-90. [PMID: 26855814 DOI: 10.4292/wjgpt.v7.i1.78] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
40 Targownik LE, Sexton KA, Bernstein MT, Beatie B, Sargent M, Walker JR, Graff LA. The Relationship Among Perceived Stress, Symptoms, and Inflammation in Persons With Inflammatory Bowel Disease. Am J Gastroenterol. 2015;110:1001-12; quiz 1013. [PMID: 26077178 DOI: 10.1038/ajg.2015.147] [Cited by in Crossref: 82] [Cited by in F6Publishing: 70] [Article Influence: 13.7] [Reference Citation Analysis]
41 Malinowski B, Wiciński M, Sokołowska MM, Hill NA, Szambelan M. The Rundown of Dietary Supplements and Their Effects on Inflammatory Bowel Disease-A Review. Nutrients 2020;12:E1423. [PMID: 32423084 DOI: 10.3390/nu12051423] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 9.0] [Reference Citation Analysis]
42 Nazarian A, Bishay K, Gholami R, Scaffidi MA, Khan R, Cohen-Lyons D, Griller N, Satchwell JB, Baker JP, Grover SC, Irvine EJ. Factors Associated with Poor Quality of Life in a Canadian Cohort of Patients with Inflammatory Bowel Disease: A Cross-sectional Study. J Can Assoc Gastroenterol 2021;4:91-6. [PMID: 33855267 DOI: 10.1093/jcag/gwaa014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Coates MD, Johri A, Gorrepati VS, Maheshwari P, Dalessio S, Walter V, Stuart A, Koltun W, Bernasko N, Tinsley A, Williams ED, Clarke K. Abdominal pain in quiescent inflammatory bowel disease. Int J Colorectal Dis 2021;36:93-102. [PMID: 32879990 DOI: 10.1007/s00384-020-03727-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Vermeulen W, De Man JG, Pelckmans PA, De Winter BY. Neuroanatomy of lower gastrointestinal pain disorders. World J Gastroenterol. 2014;20:1005-1020. [PMID: 24574773 DOI: 10.3748/wjg.v20.i4.1005] [Cited by in CrossRef: 61] [Cited by in F6Publishing: 48] [Article Influence: 8.7] [Reference Citation Analysis]
45 Zimmerman LA, Srinath AI, Goyal A, Bousvaros A, Ducharme P, Szigethy E, Nurko S. The overlap of functional abdominal pain in pediatric Crohn's disease. Inflamm Bowel Dis. 2013;19:826-831. [PMID: 23407043 DOI: 10.1097/mib.0b013e3182802a0a] [Cited by in Crossref: 49] [Cited by in F6Publishing: 16] [Article Influence: 6.1] [Reference Citation Analysis]
46 Ananthakrishnan AN, Gainer VS, Perez RG, Cai T, Cheng SC, Savova G, Chen P, Szolovits P, Xia Z, De Jager PL, Shaw SY, Churchill S, Karlson EW, Kohane I, Perlis RH, Plenge RM, Murphy SN, Liao KP. Psychiatric co-morbidity is associated with increased risk of surgery in Crohn's disease. Aliment Pharmacol Ther 2013;37:445-54. [PMID: 23289600 DOI: 10.1111/apt.12195] [Cited by in Crossref: 64] [Cited by in F6Publishing: 55] [Article Influence: 8.0] [Reference Citation Analysis]
47 Coates MD, Lahoti M, Binion DG, Szigethy EM, Regueiro MD, Bielefeldt K. Abdominal pain in ulcerative colitis. Inflamm Bowel Dis 2013;19:2207-14. [PMID: 23929261 DOI: 10.1097/MIB.0b013e31829614c6] [Cited by in Crossref: 24] [Cited by in F6Publishing: 7] [Article Influence: 3.4] [Reference Citation Analysis]
48 Hou T, Xiang H, Yu L, Su W, Shu Y, Li H, Zhu H, Lin L, Hu X, Liang S, Zhang H, Li M. Electroacupuncture inhibits visceral pain via adenosine receptors in mice with inflammatory bowel disease. Purinergic Signal 2019;15:193-204. [PMID: 31187350 DOI: 10.1007/s11302-019-09655-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
49 Trindade IA, Ferreira C, Pinto-Gouveia J. Ulcerative Colitis Symptomatology and Depression: The Exacerbator Role of Maladaptive Psychological Processes. Dig Dis Sci 2015;60:3756-63. [PMID: 26141631 DOI: 10.1007/s10620-015-3786-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
50 Wright KL, Duncan M, Sharkey KA. Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation. Br J Pharmacol. 2008;153:263-270. [PMID: 17906675 DOI: 10.1038/sj.bjp.0707486] [Cited by in Crossref: 157] [Cited by in F6Publishing: 138] [Article Influence: 11.2] [Reference Citation Analysis]
51 Moss AC. Optimizing the use of biological therapy in patients with inflammatory bowel disease. Gastroenterol Rep (Oxf). 2015;3:63-68. [PMID: 25567472 DOI: 10.1093/gastro/gou087] [Cited by in Crossref: 48] [Cited by in F6Publishing: 37] [Article Influence: 8.0] [Reference Citation Analysis]
52 Tomita T, Kato Y, Takimoto M, Yamasaki T, Kondo T, Kono T, Tozawa K, Yokoyama Y, Ikehara H, Ohda Y, Oshima T, Fukui H, Tanaka S, Shima M, Watari J, Miwa H. Prevalence of Irritable Bowel Syndrome-like Symptoms in Japanese Patients with Inactive Inflammatory Bowel Disease. J Neurogastroenterol Motil 2016;22:661-9. [PMID: 27193973 DOI: 10.5056/jnm15160] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
53 Halmos EP, Christophersen CT, Bird AR, Shepherd SJ, Muir JG, Gibson PR. Consistent Prebiotic Effect on Gut Microbiota With Altered FODMAP Intake in Patients with Crohn's Disease: A Randomised, Controlled Cross-Over Trial of Well-Defined Diets. Clin Transl Gastroenterol. 2016;7:e164. [PMID: 27077959 DOI: 10.1038/ctg.2016.22] [Cited by in Crossref: 62] [Cited by in F6Publishing: 46] [Article Influence: 12.4] [Reference Citation Analysis]
54 Timmer A, Kemptner D, Bauer A, Takses A, Ott C, Fürst A. Determinants of female sexual function in inflammatory bowel disease: a survey based cross-sectional analysis. BMC Gastroenterol 2008;8:45. [PMID: 18834529 DOI: 10.1186/1471-230X-8-45] [Cited by in Crossref: 37] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
55 Farrell KE, Callister RJ, Keely S. Understanding and targeting centrally mediated visceral pain in inflammatory bowel disease. Front Pharmacol 2014;5:27. [PMID: 24634658 DOI: 10.3389/fphar.2014.00027] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]
56 Desai D. Psychiatric morbidity in inflammatory bowel disease: Time to screen all the patients. Indian J Gastroenterol 2018;37:281-3. [PMID: 30196517 DOI: 10.1007/s12664-018-0891-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
57 West C, McVey Neufeld KA. Animal models of visceral pain and the role of the microbiome. Neurobiol Pain 2021;10:100064. [PMID: 34151049 DOI: 10.1016/j.ynpai.2021.100064] [Reference Citation Analysis]
58 Mentella MC, Scaldaferri F, Pizzoferrato M, Gasbarrini A, Miggiano GAD. Nutrition, IBD and Gut Microbiota: A Review. Nutrients 2020;12:E944. [PMID: 32235316 DOI: 10.3390/nu12040944] [Cited by in Crossref: 32] [Cited by in F6Publishing: 22] [Article Influence: 32.0] [Reference Citation Analysis]
59 Szigethy EM, Youk AO, Benhayon D, Fairclough DL, Newara MC, Kirshner MA, Bujoreanu SI, Mrakotsky C, Bousvaros A, Srinath AI, Keljo DJ, Kupfer DJ, DeMaso DR. Depression subtypes in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2014;58:574-581. [PMID: 24345836 DOI: 10.1097/mpg.0000000000000262] [Cited by in Crossref: 39] [Cited by in F6Publishing: 17] [Article Influence: 5.6] [Reference Citation Analysis]
60 Yamamoto M, Pinto-Sanchez MI, Bercik P, Britz-McKibbin P. Metabolomics reveals elevated urinary excretion of collagen degradation and epithelial cell turnover products in irritable bowel syndrome patients. Metabolomics 2019;15:82. [PMID: 31111238 DOI: 10.1007/s11306-019-1543-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 11.0] [Reference Citation Analysis]
61 Barros LL, Farias AQ, Rezaie A. Gastrointestinal motility and absorptive disorders in patients with inflammatory bowel diseases: Prevalence, diagnosis and treatment. World J Gastroenterol. 2019;25:4414-4426. [PMID: 31496621 DOI: 10.3748/wjg.v25.i31.4414] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 15] [Article Influence: 22.0] [Reference Citation Analysis]
62 Murphy LK, Rights JD, Ricciuto A, Church PC, Ahola Kohut S. Biopsychosocial Correlates of Presence and Intensity of Pain in Adolescents With Inflammatory Bowel Disease. Front Pediatr 2020;8:559. [PMID: 33014942 DOI: 10.3389/fped.2020.00559] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
63 Claar RL, van Tilburg MAL, Abdullah B, Langer S, Sherif D, Whitehead WE, Drossman DA, Levy RL. Psychological Distress and Quality of Life in Pediatric Crohn Disease: Impact of Pain and Disease State. J Pediatr Gastroenterol Nutr 2017;65:420-4. [PMID: 28945206 DOI: 10.1097/MPG.0000000000001549] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
64 Soares RL. Irritable bowel syndrome: a clinical review. World J Gastroenterol. 2014;20:12144-12160. [PMID: 25232249 DOI: 10.3748/wjg.v20.i34.12144] [Cited by in CrossRef: 90] [Cited by in F6Publishing: 72] [Article Influence: 15.0] [Reference Citation Analysis]
65 Basso L, Lapointe TK, Iftinca M, Marsters C, Hollenberg MD, Kurrasch DM, Altier C. Granulocyte-colony-stimulating factor (G-CSF) signaling in spinal microglia drives visceral sensitization following colitis. Proc Natl Acad Sci U S A 2017;114:11235-40. [PMID: 28973941 DOI: 10.1073/pnas.1706053114] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 5.8] [Reference Citation Analysis]
66 Kornelsen J, Wilson A, Labus JS, Witges K, Mayer EA, Bernstein CN. Brain Resting-State Network Alterations Associated With Crohn's Disease. Front Neurol 2020;11:48. [PMID: 32132964 DOI: 10.3389/fneur.2020.00048] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
67 Perera LP, Ananthakrishnan AN, Guilday C, Remshak K, Zadvornova Y, Naik AS, Stein DJ, Massey BT. Dyssynergic defecation: a treatable cause of persistent symptoms when inflammatory bowel disease is in remission. Dig Dis Sci. 2013;58:3600-3605. [PMID: 24026401 DOI: 10.1007/s10620-013-2850-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
68 Naliboff BD, Kim SE, Bolus R, Bernstein CN, Mayer EA, Chang L. Gastrointestinal and psychological mediators of health-related quality of life in IBS and IBD: a structural equation modeling analysis. Am J Gastroenterol. 2012;107:451-459. [PMID: 22085819 DOI: 10.1038/ajg.2011.377] [Cited by in Crossref: 57] [Cited by in F6Publishing: 47] [Article Influence: 5.7] [Reference Citation Analysis]
69 Mavroudis G, Simren M, Jonefjäll B, Öhman L, Strid H. Symptoms compatible with functional bowel disorders are common in patients with quiescent ulcerative colitis and influence the quality of life but not the course of the disease. Therap Adv Gastroenterol 2019;12:1756284819827689. [PMID: 30815033 DOI: 10.1177/1756284819827689] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]